OBJECTIVE: To investigate whether the PTPN22 1858T risk variant is associated with the rate of radiographic progression in rheumatoid arthritis (RA). METHODS: A longitudinally followed cohort of 238 Norwegian patients with RA (the EURIDISS cohort) was genotyped for the PTPN22 1858C-->T polymorphism. Radiographic damage was assessed by hand radiographs at baseline and after 1, 2, 5 and 10 years, and the radiographs were scored with the Sharp method modified by van der Heijde (Sharp-van der Heijde score) by a single experienced reader. Baseline serum levels of rheumatoid factor and anti-cyclic citrullinated peptide autoantibodies were also examined. RESULTS: The reported association between RA susceptibility and carriage of the T allele (34.4% in patients vs 21.4% in controls; odds ratio 1.92, 95% confidence interval 1.36 to 2.71, p = 0.0002) was confirmed. An association between annual progression rate of Sharp-van der Heijde score and T-allele carriers (p = 0.01),was also found, which was also present when only patients positive for the shared epitope were analysed (p = 0.03). This association was also maintained in multivariate analyses adjusting for shared epitope and demographic variables. CONCLUSIONS: An association between the PTPN22 risk variant and increased progression rate for structural damage was found. The results indicate that the PTPN22 gene may not only be associated with disease susceptibility, but also with disease progression.
OBJECTIVE: To investigate whether the PTPN22 1858T risk variant is associated with the rate of radiographic progression in rheumatoid arthritis (RA). METHODS: A longitudinally followed cohort of 238 Norwegian patients with RA (the EURIDISS cohort) was genotyped for the PTPN22 1858C-->T polymorphism. Radiographic damage was assessed by hand radiographs at baseline and after 1, 2, 5 and 10 years, and the radiographs were scored with the Sharp method modified by van der Heijde (Sharp-van der Heijde score) by a single experienced reader. Baseline serum levels of rheumatoid factor and anti-cyclic citrullinated peptide autoantibodies were also examined. RESULTS: The reported association between RA susceptibility and carriage of the T allele (34.4% in patients vs 21.4% in controls; odds ratio 1.92, 95% confidence interval 1.36 to 2.71, p = 0.0002) was confirmed. An association between annual progression rate of Sharp-van der Heijde score and T-allele carriers (p = 0.01),was also found, which was also present when only patients positive for the shared epitope were analysed (p = 0.03). This association was also maintained in multivariate analyses adjusting for shared epitope and demographic variables. CONCLUSIONS: An association between the PTPN22 risk variant and increased progression rate for structural damage was found. The results indicate that the PTPN22 gene may not only be associated with disease susceptibility, but also with disease progression.
Authors: J Wesoly; A H M van der Helm-van Mil; R E Toes; A P Chokkalingam; V E H Carlton; A B Begovich; T W J Huizinga Journal: Arthritis Rheum Date: 2005-09
Authors: Helen M A Simkins; Marilyn E Merriman; John Highton; Peter T Chapman; John L O'Donnell; Peter B B Jones; Peter J Gow; Lachy McLean; Violetta Pokorny; Andrew A Harrison; Tony R Merriman Journal: Arthritis Rheum Date: 2005-07
Authors: Anne Hinks; Anne Barton; Sally John; Ian Bruce; Clive Hawkins; Christopher E M Griffiths; Rachelle Donn; Wendy Thomson; Alan Silman; Jane Worthington Journal: Arthritis Rheum Date: 2005-06
Authors: A T Lee; W Li; A Liew; C Bombardier; M Weisman; E M Massarotti; J Kent; F Wolfe; A B Begovich; P K Gregersen Journal: Genes Immun Date: 2005-03 Impact factor: 2.676
Authors: Mark van Oene; Richard F Wintle; Xiangdong Liu; Mehrdad Yazdanpanah; Xiangjun Gu; Bill Newman; Albert Kwan; Benjamin Johnson; Julie Owen; Wenda Greer; Dianne Mosher; Walter Maksymowych; Ed Keystone; Laurence A Rubin; Christopher I Amos; Katherine A Siminovitch Journal: Arthritis Rheum Date: 2005-07
Authors: M K Viken; S S Amundsen; T K Kvien; K M Boberg; I M Gilboe; V Lilleby; L M Sollid; O T Førre; E Thorsby; A Smerdel; B A Lie Journal: Genes Immun Date: 2005-05 Impact factor: 2.676
Authors: Philippe Dieudé; Sophie Garnier; Laëtitia Michou; Elisabeth Petit-Teixeira; Elodie Glikmans; Céline Pierlot; Sandra Lasbleiz; Thomas Bardin; Bernard Prum; François Cornélis Journal: Arthritis Res Ther Date: 2005-08-25 Impact factor: 5.156
Authors: J A B van Nies; R Knevel; N Daha; M P M van der Linden; P K Gregersen; M Kern; S le Cessie; J J Houwing-Duistermaat; T W J Huizinga; R E M Toes; A H M van der Helm-van Mil Journal: Ann Rheum Dis Date: 2010-04-13 Impact factor: 19.103
Authors: Hala M Raslan; Hanaa R Attia; Iman Salama; Mona Hamed Ibrahim; Eman Mahmoud Hassan; Mohamed S El Hussieny; Manal M El Menyawi; Khalda S Amr Journal: Rheumatol Int Date: 2016-06-20 Impact factor: 2.631